Literature DB >> 26643006

Recurrent and Residual Shunts After Patent Foramen Ovale Closure: Results From a Long-Term Transcranial Doppler Study.

Martino Cheli1, Marco Canepa1,2, Claudio Brunelli1, Gian Paolo Bezante1, Serena Favorini1, Daniela Rollando1, Giorgia Sivori3, Erica Viani3, Cinzia Finocchi3, Manrico Balbi1.   

Abstract

OBJECTIVES: Assess the evolution of right-to-left shunt (RLS) after transcatheter patent foramen ovale (PFO) closure.
BACKGROUND: Despite the high number of interventional procedures performed worldwide, limited systematic data on the long-term abolition of RLS after percutaneous closure are available.
METHODS: All patients treated at our Institution between February 2001 and July 2009 were included in this single center, prospective study, and were asked to repeat late contrast transcranial Doppler (cTCD). Rate of complete closure, residual RLS (i.e., a shunt that persists after closure), and recurrent RLS (i.e., a shunt that reappears after a previous negative cTCD) was assessed.
RESULTS: Long-term follow-up was completed in 120 patients (56% male). RLS was still detectable 4.9 ± 2.3 years (range 1.3-10.3) after the procedure in 55 patients; 20 (17%) had residual RLS and 35 (29%) had recurrent RLS. Multivariate analysis revealed that significant predictors of residual RLS included post-procedural shunt at transesophageal echocardiography (OR 3.07, 95%CI 0.97-9.7), use of a bigger device (35 vs 25 mm, OR 3.85, 95%CI 1.22-12.2) and length of follow-up (OR 0.75, 95%CI 0.57-0.98), while only length of follow-up (OR 0.77, 95%CI 0.62-0.95) was associated with recurrent RLS. Neurological recurrences (1 stroke, 6 transient ischemic attacks) were equally distributed between the groups.
CONCLUSION: A significant number of recurrent and residual shunts may be observed by cTCD up to 5 years after PFO closure. Management of late RLSs includes periodic re-evaluation, exclusion of device-induced complications or secondary sources of RLS, and optimization of antithrombotic treatment with or without a second intervention.
© 2015, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26643006     DOI: 10.1111/joic.12255

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  3 in total

1.  EACVI survey on the management of patients with patent foramen ovale and cryptogenic stroke.

Authors:  Antonello D'Andrea; Marc R Dweck; Espen Holte; Ricardo Fontes-Carvalho; Matteo Cameli; Hatem Soliman Aboumarie; Hans Christoph Diener; Kristina H Haugaa
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-01-22       Impact factor: 6.875

2.  Acute cerebral infarction with acute myocardial infarction due to patent foramen ovale: A case report.

Authors:  Jinghong Chen; Rui Li; Jingjing Chen; Jingru Zhao; Na Li; Sujuan Sun; Baoming Yang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

3.  Midterm follow-up of transthoracic device closure of an atrial septal defect using the very large domestic occluder (44-48 mm), a single Chinese cardiac center experience.

Authors:  Qiang Chen; Hua Cao; Gui-Can Zhang; Liang-Wan Chen; Fan Xu; Jia-Xin Zhang
Journal:  J Cardiothorac Surg       Date:  2017-09-02       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.